The University of Southampton
University of Southampton Institutional Repository

Investigating the influence of drone flight on the stability of cancer medicines

Investigating the influence of drone flight on the stability of cancer medicines
Investigating the influence of drone flight on the stability of cancer medicines
Monoclonal Antibodies (mAbs) are being used in the treatment of both malignant and non-malignant diseases and whilst highly effective, certain products have very short expiry times. Clinical deterioration and supply chain disruption can often lead to wastage and there is a need to reduce this by improving efficiency in logistics practices between manufacturing sites and administration locations. This study aimed to investigate the influence of drone flight on the stability of cancer medicines. Clinically expired, premanufactured monoclonal antibodies (mAbs) were investigated, contained inside instrumented Versapaks, and flown in a Skylift (Mugin) V50 vertical take-off and landing drone through seven phases of flight, (take-off, hover, transition, cruise, transition, hover, and landing). Storage specifications (2-8°C) were met, and any vibrations emanating from the drone and transmitted through the packaging during flight were monitored using accelerometers. Vibration occurred largely above 44 Hz which was consistent with rotor speeds during operation and was significantly greater in amplitude during transition than in forward flight or in hover. Bench experiments validated assurance practices, exploring the edge-of-quality failure by applying extremes of rotational vibration to the mAbs. Aggregation and fragmentation represented a loss of quality in the mAbs and would pose a risk to patient safety. No significant difference was identified in the aggregation and fragmentation of all flown mAbs samples, indicating structural integrity. Flown mAbs in their infusion bags had similar particle sizes compared to controls, (Bevacizumab 11.8±0.17 nm vs. 11.6±0.05 nm, Trastuzumab 11.2±0.05 nm vs. 11.3±0.13 nm, Rituximab 11.4±0.27 nm vs. 11.5±0.05 nm) and aggregate content (Bevacizumab 1.25±0.03% vs 1.32±0.02% p=0.11, Trastuzumab 0.15±0.06% vs. 0.16±0.06% p=0.75, Rituximab 0.11±0.02% vs. 0.11±0.01% p=0.73). The quality of the three mAbs was assured, suggesting that the V50 drone did not induce sufficient levels of vibration to adversely affect their quality.
VTOL, cancer, drones, healthcare, hospital, logistics, medicine, pharmacy, safety, transport, vibration analysis
1932-6203
Zhu, Wanqing
011a289f-9f22-4743-af1c-68d7d7074d16
Oakey, Andy
dfd6e317-1e6d-429c-a3e0-bc80e92787d1
Royall, Paul
0c9ccd6d-5fa8-4faf-ad06-1a912282963c
Waters, Tim
348d22f5-dba1-4384-87ac-04fe5d603c2f
Cherrett, Thomas
e5929951-e97c-4720-96a8-3e586f2d5f95
Theobald, Katherine
2c1196be-b9f6-4c75-8552-5af1c12a6997
Bester, Ans-Mari
2dd1ee77-7031-48a4-a552-cde11237008a
Lucas, Robert
122385a8-1b63-4537-bb37-8c465ff4fc02
Zhu, Wanqing
011a289f-9f22-4743-af1c-68d7d7074d16
Oakey, Andy
dfd6e317-1e6d-429c-a3e0-bc80e92787d1
Royall, Paul
0c9ccd6d-5fa8-4faf-ad06-1a912282963c
Waters, Tim
348d22f5-dba1-4384-87ac-04fe5d603c2f
Cherrett, Thomas
e5929951-e97c-4720-96a8-3e586f2d5f95
Theobald, Katherine
2c1196be-b9f6-4c75-8552-5af1c12a6997
Bester, Ans-Mari
2dd1ee77-7031-48a4-a552-cde11237008a
Lucas, Robert
122385a8-1b63-4537-bb37-8c465ff4fc02

Zhu, Wanqing, Oakey, Andy, Royall, Paul, Waters, Tim, Cherrett, Thomas, Theobald, Katherine, Bester, Ans-Mari and Lucas, Robert (2023) Investigating the influence of drone flight on the stability of cancer medicines. PLoS ONE, 18 (1 January), [e0278873]. (doi:10.1371/journal.pone.0278873).

Record type: Article

Abstract

Monoclonal Antibodies (mAbs) are being used in the treatment of both malignant and non-malignant diseases and whilst highly effective, certain products have very short expiry times. Clinical deterioration and supply chain disruption can often lead to wastage and there is a need to reduce this by improving efficiency in logistics practices between manufacturing sites and administration locations. This study aimed to investigate the influence of drone flight on the stability of cancer medicines. Clinically expired, premanufactured monoclonal antibodies (mAbs) were investigated, contained inside instrumented Versapaks, and flown in a Skylift (Mugin) V50 vertical take-off and landing drone through seven phases of flight, (take-off, hover, transition, cruise, transition, hover, and landing). Storage specifications (2-8°C) were met, and any vibrations emanating from the drone and transmitted through the packaging during flight were monitored using accelerometers. Vibration occurred largely above 44 Hz which was consistent with rotor speeds during operation and was significantly greater in amplitude during transition than in forward flight or in hover. Bench experiments validated assurance practices, exploring the edge-of-quality failure by applying extremes of rotational vibration to the mAbs. Aggregation and fragmentation represented a loss of quality in the mAbs and would pose a risk to patient safety. No significant difference was identified in the aggregation and fragmentation of all flown mAbs samples, indicating structural integrity. Flown mAbs in their infusion bags had similar particle sizes compared to controls, (Bevacizumab 11.8±0.17 nm vs. 11.6±0.05 nm, Trastuzumab 11.2±0.05 nm vs. 11.3±0.13 nm, Rituximab 11.4±0.27 nm vs. 11.5±0.05 nm) and aggregate content (Bevacizumab 1.25±0.03% vs 1.32±0.02% p=0.11, Trastuzumab 0.15±0.06% vs. 0.16±0.06% p=0.75, Rituximab 0.11±0.02% vs. 0.11±0.01% p=0.73). The quality of the three mAbs was assured, suggesting that the V50 drone did not induce sufficient levels of vibration to adversely affect their quality.

Text
journal.pone.0278873 - Version of Record
Available under License Creative Commons Attribution.
Download (3MB)

More information

Accepted/In Press date: 24 November 2022
Published date: 6 January 2023
Additional Information: Funding Information: TC: UK EPSRC-funded e-Drone project, EP/V002619/1, (www.e-drone.org) TC: UK Department for Transport Funded Future Transport Zones Solent project (www.solent-transport.com/ solent-future-transport-zone/). WZ: King’s-China Scholarship Council (K-CSC) PhD Scholarship Programme for Zhu, W. The funders were not directly involved in this research. Publisher Copyright: Copyright: © 2023 Zhu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: VTOL, cancer, drones, healthcare, hospital, logistics, medicine, pharmacy, safety, transport, vibration analysis

Identifiers

Local EPrints ID: 473634
URI: http://eprints.soton.ac.uk/id/eprint/473634
ISSN: 1932-6203
PURE UUID: 1796dcf4-6e68-45e3-a4be-1537043f982b
ORCID for Andy Oakey: ORCID iD orcid.org/0000-0003-1796-5485
ORCID for Thomas Cherrett: ORCID iD orcid.org/0000-0003-0394-5459
ORCID for Katherine Theobald: ORCID iD orcid.org/0000-0003-2158-5346

Catalogue record

Date deposited: 25 Jan 2023 17:48
Last modified: 12 Nov 2024 03:09

Export record

Altmetrics

Contributors

Author: Wanqing Zhu
Author: Andy Oakey ORCID iD
Author: Paul Royall
Author: Tim Waters
Author: Thomas Cherrett ORCID iD
Author: Katherine Theobald ORCID iD
Author: Ans-Mari Bester
Author: Robert Lucas

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×